USPTO Patent Application for Fusion Polypeptides
Summary
The USPTO has published a new patent application (US20260085300A1) detailing systems and compositions for fusion polypeptides and their methods of use in regulating target genes. The application was filed on October 27, 2023, by inventors Thomas Blair Gainous, Xiao Yang, Giovanni Carosso, Lei S. Qi, and Daniel O. Hart, II.
What changed
This document is a publication of a new patent application filed with the USPTO, specifically application US20260085300A1, titled "SYSTEMS AND COMPOSITIONS FOR FUSION POLYPEPTIDES AND METHODS OF USE THEREOF." The application describes polypeptide molecules designed to regulate target genes within cells. The filing date was October 27, 2023, and the application number is 19123019.
As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in gene therapy or protein engineering, should be aware of this disclosure for potential intellectual property considerations and competitive intelligence. The abstract and CPC classifications provide technical details for those interested in the specific claims and scope of the invention.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEMS AND COMPOSITIONS FOR FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
Application US20260085300A1 Kind: A1 Mar 26, 2026
Inventors
THOMAS BLAIR GAINOUS, XIAO YANG, GIOVANNI CAROSSO, LEI S. QI, DANIEL O. HART, II
Abstract
The present disclosure provides polypeptide molecules comprising one or more polypeptide chains and systems, compositions, and methods of use thereof, wherein the polypeptide molecule comprising one or more polypeptide chains (or engineered polypeptide chain) can be used to effect regulation of a target gene in a cell (e.g., an endogenous target gene in a cell).
CPC Classifications
C12N 9/226 C07K 14/4703 C07K 2319/00
Filing Date
2023-10-27
Application No.
19123019
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.